' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

Publikationen

Gewähltes Keyword: Stromal cells


Heparin Differentially Impacts Gene Expression of Stromal Cells from Various Tissues.
Laner-Plamberger, S; Oeller, M; Poupardin, R; Krisch, L; Hochmann, S; Kalathur, R; Pachler, K; Kreutzer, C; Erdmann, G; Rohde, E; Strunk, D; Schallmoser, K;
Sci Rep. 2019; 9(1):7258
Originalarbeiten (Zeitschrift)
Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing.
Rohde, E; Pachler, K; Gimona, M
Cytotherapy. 2019; 21(6):581-592
Übersichtsarbeiten
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis
Uccelli, A; Laroni, A; Brundin, L; Clanet, M; Fernandez, O; Nabavi, SM; Muraro, PA; Oliveri, RS; Radue, EW; Sellner, J; Sorensen, PS; Sormani, MP; Wuerfel, JT; Battaglia, MA; Freedman, MS
TRIALS. 2019; 20: 263
Originalarbeiten (Zeitschrift)
Decellularized Iliotibial Band Recolonized with Allogenic Homotopic Fibroblasts or Bone Marrow-Derived Mesenchymal Stromal Cells.
Gögele, C; Schwarz, S; Ondruschka, B; Hammer, N; Schulze-Tanzil, G;
Methods Mol Biol. 2018; 1577:55-69
Originalarbeiten (Zeitschrift)
Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1.
Hoeres, T; Wilhelm, M; Smetak, M; Holzmann, E; Schulze-Tanzil, G; Birkmann, J;
Clin Exp Immunol. 2018; 192(1):54-67
Originalarbeiten (Zeitschrift)
Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia.
Janovska, P; Verner, J; Kohoutek, J; Bryjova, L; Gregorova, M; Dzimkova, M; Skabrahova, H; Radaszkiewicz, T; Ovesna, P; Blanarova, OV; Nemcova, T; Hoferova, Z; Vasickova, K; Smyckova, L; Egle, A; Pavlova, S; Poppova, L; Plevova, K; Pospisilova, S; Bryja, V
BLOOD. 2018; 131(11): 1206-1218.
Originalarbeiten (Zeitschrift)
Selection of Tissue Factor-Deficient Cell Transplants as a Novel Strategy for Improving Hemocompatibility of Human Bone Marrow Stromal Cells
Oeller, M; Laner-Plamberger, S; Hochmann, S; Ketterl, N; Feichtner, M; Brachtl, G; Hochreiter, A; Scharler, C; Bieler, L; Romanelli, P; Couillard-Despres, S; Russe, E; Schallmoser, K; Strunk, D
THERANOSTICS. 2018; 8(5): 1421-1434.
Originalarbeiten (Zeitschrift)
Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation.
Trento, C; Bernardo, ME; Nagler, A; Kuçi, S; Bornhäuser, M; Köhl, U; Strunk, D; Galleu, A; Sanchez-Guijo, F; Gaipa, G; Introna, M; Bukauskas, A; Le Blanc, K; Apperley, J; Roelofs, H; Van Campenhout, A; Beguin, Y; Kuball, J; Lazzari, L; Avanzini, MA; Fibbe, W; Chabannon, C; Bonini, C; Dazzi, F;
Biol Blood Marrow Transplant. 2018; 24(11):2365-2370
Originalarbeiten (Zeitschrift)
Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use.
Gimona, M; Pachler, K; Laner-Plamberger, S; Schallmoser, K; Rohde, E;
Int J Mol Sci. 2017; 18(6):
Originalarbeiten (Zeitschrift)
The Challenge in Using Mesenchymal Stromal Cells for Recellularization of Decellularized Cartilage.
Huang, Z; Godkin, O; Schulze-Tanzil, G;
Stem Cell Rev. 2017; 13(1): 50-67.
Übersichtsarbeiten
Distribution of the neuro-regulatory peptide galanin in the human eye.
Kaser-Eichberger, A; Trost, A; Strohmaier, C; Bogner, B; Runge, C; Bruckner, D; Hohberger, B; Jünemann, A; Kofler, B; Reitsamer, HA; Schrödl, F;
Neuropeptides. 2017; 64:85-93
Originalarbeiten (Zeitschrift)
Comparing the osteogenic potential of bone marrow and tendon-derived stromal cells to repair a critical-sized defect in the rat femur.
Kunkel, N; Wagner, A; Gehwolf, R; Heimel, P; Tempfer, H; Korntner, S; Augat, P; Resch, H; Redl, H; Betz, O; Bauer, HC; Traweger, A;
J Tissue Eng Regen Med. 2017; 11(7):2014-2023
Originalarbeiten (Zeitschrift)
An In Vitro Potency Assay for Monitoring the Immunomodulatory Potential of Stromal Cell-Derived Extracellular Vesicles.
Pachler, K; Ketterl, N; Desgeorges, A; Dunai, ZA; Laner-Plamberger, S; Streif, D; Strunk, D; Rohde, E; Gimona, M;
Int J Mol Sci. 2017; 18(7):
Originalarbeiten (Zeitschrift)
A Good Manufacturing Practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles.
Pachler, K; Lener, T; Streif, D; Dunai, ZA; Desgeorges, A; Feichtner, M; Öller, M; Schallmoser, K; Rohde, E; Gimona, M;
Cytotherapy. 2017; 19(4): 458-472.
Originalarbeiten (Zeitschrift)
Current and Future Perspectives of Stem Cell Therapy in Dermatology.
Prodinger, CM; Reichelt, J; Bauer, JW; Laimer, M;
Ann Dermatol. 2017; 29(6):-687
Übersichtsarbeiten
Generation and use of a humanized bone-marrow-ossicle niche for hematopoietic xenotransplantation into mice.
Reinisch, A; Hernandez, DC; Schallmoser, K; Majeti, R;
Nat Protoc. 2017; 12(10): 2169-2188.
Originalarbeiten (Zeitschrift)
Stromal Cells Act as Guardians for Endothelial Progenitors by Reducing Their Immunogenicity After Co-Transplantation.
Souidi, N; Stolk, M; Rudeck, J; Strunk, D; Schallmoser, K; Volk, HD; Seifert, M;
Stem Cells. 2017; 35(5): 1233-1245.
Originalarbeiten (Zeitschrift)
Establishment of a Cytocompatible Cell-Free Intervertebral Disc Matrix for Chondrogenesis with Human Bone Marrow-Derived Mesenchymal Stromal Cells.
Huang, Z; Kohl, B; Kokozidou, M; Arens, S; Schulze-Tanzil, G
Cells Tissues Organs. 2016; 201(5):354-365
Originalarbeiten (Zeitschrift)
Selective renal blood perfusion induces renal tubules injury in a porcine model.
Kalder, J; Kokozidou, M; Keschenau, P; Tamm, M; Greiner, A; Koeppel, TA; Tolba, R; Jacobs, MJ;
J Vasc Surg. 2016; 63(3): 778-787.
Originalarbeiten (Zeitschrift)
Cryopreserved or Fresh Mesenchymal Stromal Cells: Only a Matter of Taste or Key to Unleash the Full Clinical Potential of MSC Therapy?
Moll, G; Geißler, S; Catar, R; Ignatowicz, L; Hoogduijn, MJ; Strunk, D; Bieback, K; Ringdén, O;
Adv Exp Med Biol. 2016; 951: 77-98.
Originalarbeiten (Zeitschrift)
A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells.
Reinisch, A; Thomas, D; Corces, MR; Zhang, X; Gratzinger, D; Hong, WJ; Schallmoser, K; Strunk, D; Majeti, R;
Nat Med. 2016; 22(7): 812-821.
Originalarbeiten (Zeitschrift)
Lymphotoxin-β receptor in microenvironmental cells promotes the development of T-cell acute lymphoblastic leukaemia with cortical/mature immunophenotype.
Fernandes, MT; Ghezzo, MN; Silveira, AB; Kalathur, RK; Póvoa, V; Ribeiro, AR; Brandalise, SR; Dejardin, E; Alves, NL; Ghysdael, J; Barata, JT; Yunes, JA; Dos Santos, NR;
Br J Haematol. 2015; 171(5): 736-751.
Originalarbeiten (Zeitschrift)
Chondrogenesis of human bone marrow mesenchymal stromal cells in highly porous alginate-foams supplemented with chondroitin sulfate.
Huang, Z; Nooeaid, P; Kohl, B; Roether, JA; Schubert, DW; Meier, C; Boccaccini, AR; Godkin, O; Ertel, W; Arens, S; Schulze-Tanzil, G
MAT SCI ENG C-MATER. 2015; 50: 160-172.
Originalarbeiten (Zeitschrift)
Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation.
Reinisch, A; Etchart, N; Thomas, D; Hofmann, NA; Fruehwirth, M; Sinha, S; Chan, CK; Senarath-Yapa, K; Seo, EY; Wearda, T; Hartwig, UF; Beham-Schmid, C; Trajanoski, S; Lin, Q; Wagner, W; Dullin, C; Alves, F; Andreeff, M; Weissman, IL; Longaker, MT; Schallmoser, K; Majeti, R; Strunk, D;
Blood. 2015; 125(2): 249-260.
Originalarbeiten (Zeitschrift)
Tendon Vasculature in Health and Disease.
Tempfer, H; Traweger, A;
Front Physiol. 2015; 6: 330
Übersichtsarbeiten
Inhibition of prostate smooth muscle contraction and prostate stromal cell growth by the inhibitors of Rac, NSC23766 and EHT1864.
Wang, Y; Kunit, T; Ciotkowska, A; Rutz, B; Schreiber, A; Strittmatter, F; Waidelich, R; Liu, C; Stief, CG; Gratzke, C; Hennenberg, M;
Br J Pharmacol. 2015; 172(11): 2905-2917.
Originalarbeiten (Zeitschrift)
Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance.
Jacamo, R; Chen, Y; Wang, Z; Ma, W; Zhang, M; Spaeth, EL; Wang, Y; Battula, VL; Mak, PY; Schallmoser, K; Ruvolo, P; Schober, WD; Shpall, EJ; Nguyen, MH; Strunk, D; Bueso-Ramos, CE; Konoplev, S; Davis, RE; Konopleva, M; Andreeff, M;
Blood. 2014; 123(17): 2691-2702.
Originalarbeiten (Zeitschrift)
The influence of IL-10 and TNFα on chondrogenesis of human mesenchymal stromal cells in three-dimensional cultures.
Jagielski, M; Wolf, J; Marzahn, U; Völker, A; Lemke, M; Meier, C; Ertel, W; Godkin, O; Arens, S; Schulze-Tanzil, G;
Int J Mol Sci. 2014; 15(9): 15821-15844.
Originalarbeiten (Zeitschrift)
Mesenchymal stromal cells from the human placenta promote neovascularization in a mouse model in vivo.
Kinzer, M; Hingerl, K; Konig, J; Reinisch, A; Strunk, D; Huppertz, B; Lang, I
PLACENTA. 2014; 35(7): 517-519.
Originalarbeiten (Zeitschrift)
Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment.
Battula, VL; Chen, Y; Cabreira, MD; Ruvolo, V; Wang, ZQ; Ma, WC; Konoplev, S; Shpall, E; Lyons, K; Strunk, D; Bueso-Ramos, C; Davis, RE; Konopleva, M; Andreeff, M
Blood. 2013; 122(3):357-366
Originalarbeiten (Zeitschrift)
CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility.
Girbl, T; Hinterseer, E; Grössinger, EM; Asslaber, D; Oberascher, K; Weiss, L; Hauser-Kronberger, C; Neureiter, D; Kerschbaum, H; Naor, D; Alon, R; Greil, R; Hartmann, TN;
Cancer Res. 2013; 73(2): 561-570.
Originalarbeiten (Zeitschrift)
Protein kinase c-β-dependent activation of NF-κB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivo.
Lutzny, G; Kocher, T; Schmidt-Supprian, M; Rudelius, M; Klein-Hitpass, L; Finch, AJ; Dürig, J; Wagner, M; Haferlach, C; Kohlmann, A; Schnittger, S; Seifert, M; Wanninger, S; Zaborsky, N; Oostendorp, R; Ruland, J; Leitges, M; Kuhnt, T; Schäfer, Y; Lampl, B; Peschel, C; Egle, A; Ringshausen, I;
Cancer Cell. 2013; 23(1):77-92
Originalarbeiten (Zeitschrift)
Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation.
Ansari, M; Strunk, D; Schallmoser, K; Delcò, C; Rougemont, AL; Moll, S; Villard, J; Gumy-Pause, F; Chalandon, Y; Parvex, P; Passweg, J; Ozsahin, H; Kindler, V;
Pediatr Transplant. 2012; 16(2):131-136
Originalarbeiten (Zeitschrift)
Incorporation of phosphate group modulates bone cell attachment and differentiation on oligo(polyethylene glycol) fumarate hydrogel.
Dadsetan, M; Giuliani, M; Wanivenhaus, F; Brett Runge, M; Charlesworth, JE; Yaszemski, MJ;
ACTA BIOMATER. 2012; 8(4): 1430-1439.
Originalarbeiten (Zeitschrift)
Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.
Brachtl, G; Sahakyan, K; Denk, U; Girbl, T; Alinger, B; Hofbauer, SW; Neureiter, D; Hofbauer, JP; Egle, A; Greil, R; Hartmann, TN;
PLoS One. 2011; 6(8):e23758
Originalarbeiten (Zeitschrift)
KATP channels in mesenchymal stromal stem cells: strong up-regulation of Kir6.2 subunits upon osteogenic differentiation.
Diehlmann, A; Bork, S; Saffrich, R; Veh, RW; Wagner, W; Derst, C
Tissue Cell. 2011; 43(5):331-336
Originalarbeiten (Zeitschrift)
[Treatment of critical limb ischemia and diabetic foot disease by the use of autologous stem cells].
Dubský, M; Jirkovská, A; Bém, R; Pagácová, L; Fejfarová, V; Varga, M; Skibová, J; Langkramer, S; Syková, E;
Vnitr Lek. 2011; 57(5):451-455
Originalarbeiten (Zeitschrift)
Expression of podoplanin and other lymphatic markers in the human anterior eye segment.
Birke, K; Lütjen-Drecoll, E; Kerjaschki, D; Birke, MT;
Invest Ophthalmol Vis Sci. 2010; 51(1): 344-354.
Originalarbeiten (Zeitschrift)
Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells.
Desch, P; Asslaber, D; Kern, D; Schnidar, H; Mangelberger, D; Alinger, B; Stoecher, M; Hofbauer, SW; Neureiter, D; Tinhofer, I; Aberger, F; Hartmann, TN; Greil, R;
Oncogene. 2010; 29(35): 488-495.
Originalarbeiten (Zeitschrift)
Modifying akt signaling in B-cell chronic lymphocytic leukemia cells.
Hofbauer, SW; Piñón, JD; Brachtl, G; Haginger, L; Wang, W; Jöhrer, K; Tinhofer, I; Hartmann, TN; Greil, R;
Cancer Res. 2010; 70(18):7336-7344
Originalarbeiten (Zeitschrift)
Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions.
Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Horn, P; Ho, AD; Strunk, D; Wagner, W;
HAEMATOL-HEMATOL J. 2010; 95(6): 86-74.
Originalarbeiten (Zeitschrift)
Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.
Bieback, K; Hecker, A; Kocaömer, A; Lannert, H; Schallmoser, K; Strunk, D; Klüter, H;
Stem Cells. 2009; 27(9): 233-241.
Originalarbeiten (Zeitschrift)
Isolation and animal serum free expansion of human umbilical cord derived mesenchymal stromal cells (MSCs) and endothelial colony forming progenitor cells (ECFCs).
Reinisch, A; Strunk, D;
J Vis Exp. 2009; (32):
Originalarbeiten (Zeitschrift)
Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells.
Schallmoser, K; Rohde, E; Bartmann, C; Obenauf, AC; Reinisch, A; Strunk, D;
Biomed Mater Eng. 2009; 19(4-5): 271-276.
Originalarbeiten (Zeitschrift)
Clinical Protocols for the Isolation and Expansion of Mesenchymal Stromal Cells.
Bieback, K; Schallmoser, K; Klutera, H; Strunk, D
TRANSFUS MED HEMOTH. 2008; 35(4): 286-294.
Originalarbeiten (Zeitschrift)
Two steps to functional mesenchymal stromal cells for clinical application.
Bartmann, C; Rohde, E; Schallmoser, K; Pürstner, P; Lanzer, G; Linkesch, W; Strunk, D;
Transfusion. 2007; 47(8): 1426-1435.
Originalarbeiten (Zeitschrift)
Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application.
Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D;
Regen Med. 2007; 2(4):371-382
Originalarbeiten (Zeitschrift)
Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells.
Schallmoser, K; Bartmann, C; Rohde, E; Reinisch, A; Kashofer, K; Stadelmeyer, E; Drexler, C; Lanzer, G; Linkesch, W; Strunk, D;
Transfusion. 2007; 47(8):143-146
Originalarbeiten (Zeitschrift)
CD45-positive cells of haematopoietic origin enhance chondrogenic marker gene expression in rat marrow stromal cells.
Ahmed, N; Vogel, B; Rohde, E; Strunk, D; Grifka, J; Schulz, MB; Grassel, S
Int J Mol Med. 2006; 18(2):233-240
Originalarbeiten (Zeitschrift)
Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.
Burger, M; Hartmann, T; Krome, M; Rawluk, J; Tamamura, H; Fujii, N; Kipps, TJ; Burger, JA;
Blood. 2005; 106(5):1824-1830
Originalarbeiten (Zeitschrift)
CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.
Hartmann, TN; Burger, JA; Glodek, A; Fujii, N; Burger, M;
Oncogene. 2005; 24(27):4462-4471
Originalarbeiten (Zeitschrift)
[Umbilical cord stromal cells (UCSC). Cells featuring osteogenic differentiation potential].
Eblenkamp, M; Aigner, J; Hintermair, J; Potthoff, S; Hopfner, U; Jacobs, V; Niemeyer, M; Wintermantel, E;
Orthopade. 2004; 33(12): 1338-1345.
Originalarbeiten (Zeitschrift)
The role of adhesion molecules and chemokine receptor CXCR4 (CD184) in small cell lung cancer.
Hartmann, TN; Burger, M; Burger, JA;
J Biol Regul Homeost Agents. 2004; 18(2):126-130
Übersichtsarbeiten
Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells.
Burger, M; Glodek, A; Hartmann, T; Schmitt-Gräff, A; Silberstein, LE; Fujii, N; Kipps, TJ; Burger, JA;
Oncogene. 2003; 22(50):8093-8101
Originalarbeiten (Zeitschrift)